‘Open & Constructive’: Early Feedback Supports Simultaneous Scientific Advice In Europe
16 Meetings Have Taken Place So Far
Executive Summary
A European pilot project that lets drug companies developing innovative products receive scientific advice from two EU member states at the same time is proving its worth during the pandemic.
You may also be interested in...
EU Refines Simultaneous Scientific Advice Pilot With Focus On Clinical Trials
Improvements have been made to the second phase of an EU pilot that allows drug sponsors to obtain simultaneous scientific advice from two member states.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add five new products, including Enjaymo, Sanofi’s treatment for hemolytic anemia in adult patients with cold agglutinin disease.
EPO Supports Early Unitary Patent Uptake From 1 January
The European Patent Office has adjusted the starting date of its transitional measures for applicants that want their patent to have unitary effect under the coming Unified Patent Court system.